Zions Bancorporation’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
RA
Zions Bancorporation's HAE Position: Q4 2024 in Review
Zions Bancorporation increased its Haemonetics (HAE) stake by 56% in Q4 2024, buying an estimated $1.19M and bringing the position to 40,996 shares worth $3.2M. The position accounts for 0.2% of the portfolio, ranked #98.
Zions Bancorporation first reported a position in HAE in Q1 2020 and has held it in 20 quarters since. 309 funds tracked by Wall St. Rank hold HAE as of Q4 2024.
- Zions Bancorporation held 40,996 shares of Haemonetics worth $3.2M as of Q4 2024.
- Zions Bancorporation bought 14,762 Haemonetics shares in Q4 2024, an estimated $1.19M.
- Haemonetics made up 0.2% of Zions Bancorporation's portfolio in Q4 2024, its #98 holding.
- Zions Bancorporation first reported a position in Haemonetics in Q1 2020 and has held it in 20 quarters since.
- 309 funds tracked by Wall St. Rank held Haemonetics as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.